March 2018
Germany

 

Press Releases

Here you will find the most up to date news and press releases in the ADC space.

macrogenics-thumbnaik

MacroGenics Licenses Synthon’s Technology to Develop an Anti-B7-H3 ADC

View here

Yahoo press release tnNew Data Demonstrate that Synaffix ADCs Significantly Expand the Therapeutic Index vs Cysteine-Engineered ADCs

View Here

biomed-thumnailMersana Announces FDA Clearance of IND Application for Lead Antibody-Drug Conjugate XMT-1522

Press release thumbnail

MedImmune and Tanabe Research Laboratories have entered into a strategic collaboration

View here

Seattle Genetics Highlights Data from DenintuzumabSeattle Genetics Highlights Data from Denintuzumab Mafodotin (SGN-CD19A) Antibody-Drug Conjugate Program at ASH 2015

View here

 BiotAtla enters into strategic license resized BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics

View here

‘Stealth bomb’ antibiotic vanquishes drug-resistant bacteria‘Stealth bomb’ antibiotic vanquishes drug-resistant bacteria

View here

Seattle Genetics Initiates Phase 2 Clinical Trial of Denintuzumab MafodotinSeattle Genetics Initiates Phase 2 Clinical Trial of Denintuzumab Mafodotin (SGN-CD19A) Combination Therapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

View here

ADC Bio - US$10m cancer drug production expansionADC Bio – US$10m cancer drug production exp

View here

Seattle Genetics Announces Initiation of Phase 1Seattle Genetics Announces Initiation of Phase 1/2 Clinical Trial of ADCETRIS® (Brentuximab Vedotin)in Combination with Opdivo® (Nivolumab) in Second-line Hodgkin Lymphoma

View here

Mitsubishi Tanabe Pharma EnterMitsubishi Tanabe Pharma Enter Into Strategic Collaboration and Licensing Agreement for the Development of Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugates to Treat Cancer

View here

THIOMAB Antibiotic Conjugate (TAC) A Novel Platform for Invasive Staphylococcus aureus InfectionTHIOMAB Antibiotic Conjugate (TAC): A Novel Platform for Invasive Staphylococcus aureus Infection

View here

merca-screenshotMersena Therapeutics’ Receives “Best ADC Platform Technology” Honors at World ADC Conference

View here